
doi: 10.1136/vr.101.3.50
pmid: 888323
Enflurane (Ethrane; Abbott Laboratories Ltd), a new inhalation anaesthetic, was used on 30 clinical cases. A surgical plane of anaesthesia was quickly obtained and recovery was rapid. Respiratory depression occurred with a reduction in rate which was more marked in deeper planes of anaesthesia. Hypotension was not severe and was more marked in deeper plans of anaesthesia. Clinically the agent did not appear to be a good analgesic. No signs of spontaneous muscle activity were seen, possibly due to premedication with acepromazine.
Enflurane, Male, Methyl Ethers, Dogs, Respiration, Animals, Blood Pressure, Female, Anesthesia, Inhalation
Enflurane, Male, Methyl Ethers, Dogs, Respiration, Animals, Blood Pressure, Female, Anesthesia, Inhalation
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 1 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
